Brødkrumme Forside Enliven Therapeutics Enliven Therapeutics Enliven Therapeutics is developing a novel, chronic, oral treatment for patients with sickle cell disease and other haemoglobinopathies. Enliven Therapeutics' website Lundbeckfonden BioCapital Investeringsår 2016 IPO in 2020 – ENVL (Nasdaq) Lokation Boston, Massachusetts, USA